Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages

Vascular Pharmacology

Volumn 85, Issue , 2016, Pages 57-65

  Carbone, Federico ^a   Satta, Nathalie ^b   Burger, Fabienne ^c   Roth, Aline ^c   Lenglet, Sébastien ^c   Pagano, Sabrina ^b   Lescuyer, Pierre ^b   Bertolotto, Maria ^a   Spinella, Giovanni ^d   Pane, Bianca ^d   Palombo, Domenico ^d   Pende, Aldo ^a,d   Dallegri, Franco ^a,d   Mach, François ^c   Vuilleumier, Nicolas ^b   Montecucco, Fabrizio ^a,d  

^a UNIVERSITY OF GENOA   (Italy)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Atherosclerosis; Macrophage; Major adverse cardiovascular events; Vitamin D; Vitamin D receptor

Indexed keywords

TOLL LIKE RECEPTOR 4; VITAMIN D RECEPTOR; CALCITRIOL; CALCITRIOL RECEPTOR;

AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITAMIN BLOOD LEVEL; CARDIOVASCULAR DISEASES; GENETICS; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PILOT STUDY; PROPORTIONAL HAZARDS MODEL;

AGED; CALCITRIOL; CARDIOVASCULAR DISEASES; CAROTID STENOSIS; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MALE; MONOCYTES; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CALCITRIOL; TOLL-LIKE RECEPTOR 4;

EID: 84990047896     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2016.08.004     Document Type: Article

References (31)

1. [1] Carbone, F., Montecucco, F., The role of the intraplaque vitamin d system in atherogenesis. Scientifica (Cairo), 2013, 2013, 620504.
2. [2] Carbone, F., Mach, F., Vuilleumier, N., Montecucco, F., Potential pathophysiological role for the vitamin D deficiency in essential hypertension. World J. Cardiol. 6 (2014), 260–276.
3. [3] Zittermann, A., Gummert, J.F., Borgermann, J., The role of vitamin D in dyslipidemia and cardiovascular disease. Curr. Pharm. Des. 17 (2011), 933–942.
4. [4] Al-Shoumer, K.A., Al-Essa, T.M., Is there a relationship between vitamin D with insulin resistance and diabetes mellitus?. World J. Diabetes 6 (2015), 1057–1064.
5. [5] Strange, R.C., Shipman, K.E., Ramachandran, S., Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World J. Diabetes 6 (2015), 896–911.
6. [6] Vaidya, A., Brown, J.M., Williams, J.S., The renin-angiotensin-aldosterone system and calcium-regulatory hormones. J. Hum. Hypertens. 29 (2015), 515–521.
7. [7] Quarles, L.D., Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat. Rev. Endocrinol. 8 (2012), 276–286.
8. [8] Montecucco, F., Braunersreuther, V., Burger, F., Lenglet, S., Pelli, G., Carbone, F., et al. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4. Thromb. Haemost. 114 (2015), 410–422.
9. [9] North American Symptomatic Carotid Endarterectomy Trial C, Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325 (1991), 445–453.
10. [10] Vuilleumier, N., Montecucco, F., Spinella, G., Pagano, S., Bertolotto, M., Pane, B., et al. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. Thromb. Haemost. 109 (2013), 706–715.
11. [11] Montecucco, F., Lenglet, S., Gayet-Ageron, A., Bertolotto, M., Pelli, G., Palombo, D., et al. Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 41 (2010), 1394–1404.
12. [12] Barnett, H.J., Taylor, D.W., Eliasziw, M., Fox, A.J., Ferguson, G.G., Haynes, R.B., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N. Engl. J. Med. 339 (1998), 1415–1425.
13. [13] Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST). Lancet, 351, 1998, 1379–1387.
14. [14] Halliday, A., Mansfield, A., Marro, J., Peto, C., Peto, R., Potter, J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363 (2004), 1491–1502.
15. [15] Montecucco, F., Di Marzo, V., da Silva, R.F., Vuilleumier, N., Capettini, L., Lenglet, S., et al. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur. Heart J. 33 (2012), 846–856.
16. [16] Stoger, J.L., Gijbels, M.J., van der Velden, S., Manca, M., van der Loos, C.M., Biessen, E.A., et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225 (2012), 461–468.
17. [17] Montecucco, F., Vuilleumier, N., Pagano, S., Lenglet, S., Bertolotto, M., Braunersreuther, V., et al. Anti-apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. Eur. Heart J. 32 (2011), 412–421.
18. [18] Satta, N., Kruithof, E.K., Fickentscher, C., Dunoyer-Geindre, S., Boehlen, F., Reber, G., et al. Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood 117 (2011), 5523–5531.
19. [19] Zhang, X., Zhou, M., Guo, Y., Song, Z., Liu, B., 1,25-Dihydroxyvitamin D(3) promotes high glucose-induced M1 macrophage switching to M2 via the VDR-PPARgamma signaling pathway. Biomed. Res. Int., 2015, 2015, 157834.
20. [20] Schnatz, P.F., Nudy, M., O'Sullivan, D.M., Jiang, X., Cline, J.M., Kaplan, J.R., et al. The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis. Maturitas 73 (2012), 143–147.
21. [21] Kwak, B.R., Back, M., Bochaton-Piallat, M.L., Caligiuri, G., Daemen, M.J., Davies, P.F., et al. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur. Heart J., 35(3013–3020), 2014 3020a-3020d.
22. [22] Seneviratne, A.N., Cole, J.E., Goddard, M.E., Park, I., Mohri, Z., Sansom, S., et al. Low shear stress induces M1 macrophage polarization in murine thin-cap atherosclerotic plaques. J. Mol. Cell. Cardiol. 89 (2015), 168–172.
23. [23] Ojaimi, S., Skinner, N.A., Strauss, B.J., Sundararajan, V., Woolley, I., Visvanathan, K., Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study. J. Transl. Med., 11, 2013, 176.
24. [24] Verma, R., Jung, J.H., Kim, J.Y., 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1. J. Steroid Biochem. Mol. Biol. 141 (2014), 1–6.
25. 2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients. J. Steroid Biochem. Mol. Biol. 136 (2013), 309–312.
26. [26] Riek, A.E., Oh, J., Darwech, I., Moynihan, C.E., Bruchas, R.R., Bernal-Mizrachi, C., 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J. Steroid Biochem. Mol. Biol. 144:Pt A (2014), 172–179.
27. [27] Karkeni, E., Marcotorchino, J., Tourniaire, F., Astier, J., Peiretti, F., Darmon, P., et al. Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology 156 (2015), 1782–1793.
28. [28] Riek, A.E., Oh, J., Sprague, J.E., Timpson, A., de las Fuentes, L., Bernal-Mizrachi, L., et al. Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J. Biol. Chem. 287 (2012), 38482–38494.
29. [29] Liu, P.T., Stenger, S., Li, H., Wenzel, L., Tan, B.H., Krutzik, S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 24;311:5768 (2006), 1770–1773.
30. [30] Di Rosa, M., Malaguarnera, G., De Gregorio, C., Palumbo, M., Nunnari, G., Malaguarnera, L., Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell. Immunol. 280 (2012), 36–43.
31. [31] Kawanishi, N., Yano, H., Yokogawa, Y., Suzuki, K., Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 16 (2010), 105–118.